Variability in the levels of PML-RARα fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols

Haematologica

Volumn 86, Issue 6, 2001, Pages 570-576

  Bolufer, P ^a   Lo Coco, F ^a   Grimwade, D ^a   Barragan E ^a   Diverio, D ^a   Cassinat, B ^a   Chomienne, C ^a   Gonzalez, M ^a   Colomer, D ^a   Gomez, M T ^a   Marugan, I ^a   Roman J ^a   Delgado, M D ^a   Garcia Marco J A ^a   Bornstein, R ^a   Vizmanos, J L ^a   Martinez, B ^a   Jansen, J ^a   Villegas, A ^a   De Blas, J M ^a   Cabello, P ^a   Sanz, M A ^a   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute promyelocytic leukemia; External quality assessment program; PML RAR; RT PCR; Sensitivity

Indexed keywords

HYBRID PROTEIN; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN RAR ALPHA; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LABORATORY DIAGNOSIS; ONCOGENE; PROTEIN ANALYSIS; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMANS; LABORATORIES; NEOPLASM PROTEINS; OBSERVER VARIATION; ONCOGENE PROTEINS, FUSION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034950570     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Quantification of PML-RARα transcripts in acute promyelocytic leukaemia: Explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by α interferon
2. Minimal residual disease after allogenic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase correlations with acute graft-versus-host disease and relapse
3. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia
4. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction
5. Occurrence of distinct PML-RAR-α fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction
6. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial
7. RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL
8. Preliminary experience in external quality control of RT-PCR PML-RAR α detection in promyelocytic leukemia
9. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
10. Diagnosis of acute promyelocytic leukaemia by RT-PCR: Detection of PML-RARα and RARα-PML fusion transcripts
11. Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse
12. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA
13. A PML/retinoic acid receptor α fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia
14. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission
15. Characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid
16. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
17. European standardization and quality control program of real time quantitative RT-PCR analysis of fusion gene transcripts for minimal residual disease detection in leukemia patients
18. Quantitation of minimal residual diease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR
19. The APL-associated fusion proteins
20. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia
21. Development and overcoming of ATRA resistance in acute promyelocytic leukemia
22. Arsenicals and inhibitors of histone deacetylase as anticancer therapy